Treatment-related amenorrhea with T-DM1 plus pertuzumab (KP) is lower than with docetaxel/carboplatin/ trastuzumab/pertuzumab (TCHP) in the phase III neoadjuvant KRISTINE trial
Hurvitz SA, Fresco R, Afenjar K, Stroyakovskiy D, Huang CS, Wildiers H, Jung KH, Boileau JF, Campone M, Martin M, Valero V, Sparano JA, Symmans WF, Fasching P, Thompson AM, Harbeck N, Lopez-Valverde V, Song C, Boulet T, Restuccia E, Slamon DJ (2021)
Publication Type: Conference contribution
Publication year: 2021
Journal
Publisher: AMER ASSOC CANCER RESEARCH
City/Town: PHILADELPHIA
Conference Proceedings Title: CANCER RESEARCH
DOI: 10.1158/1538-7445.sabcs20-pd12-06
Authors with CRIS profile
Involved external institutions
Institut de Cancérologie de l'Ouest
France (FR)
Houston Texas Medical Center
United States (USA) (US)
University of California Los Angeles (UCLA)
United States (USA) (US)
National Taiwan University (NTU)
Taiwan (TW)
University of Texas MD Anderson Cancer Center
United States (USA) (US)
Montefiore Medical Center
United States (USA) (US)
Genentech Inc.
United States (USA) (US)
McGill University
Canada (CA)
F. Hoffmann-La Roche Ltd
Switzerland (CH)
Ludwig-Maximilians-Universität (LMU)
Germany (DE)
Universidad Complutense de Madrid (UCM)
Spain (ES)
University of Ulsan / 울산대학교
Korea, Republic of (KR)
Moscow City Oncology Hospital №62
Russian Federation (RU)
University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven
Belgium (BE)
France (FR)
Houston Texas Medical Center
United States (USA) (US)
University of California Los Angeles (UCLA)
United States (USA) (US)
National Taiwan University (NTU)
Taiwan (TW)
University of Texas MD Anderson Cancer Center
United States (USA) (US)
Montefiore Medical Center
United States (USA) (US)
Genentech Inc.
United States (USA) (US)
McGill University
Canada (CA)
F. Hoffmann-La Roche Ltd
Switzerland (CH)
Ludwig-Maximilians-Universität (LMU)
Germany (DE)
Universidad Complutense de Madrid (UCM)
Spain (ES)
University of Ulsan / 울산대학교
Korea, Republic of (KR)
Moscow City Oncology Hospital №62
Russian Federation (RU)
University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven
Belgium (BE)
How to cite
APA:
Hurvitz, S.A., Fresco, R., Afenjar, K., Stroyakovskiy, D., Huang, C.-S., Wildiers, H.,... Slamon, D.J. (2021). Treatment-related amenorrhea with T-DM1 plus pertuzumab (KP) is lower than with docetaxel/carboplatin/ trastuzumab/pertuzumab (TCHP) in the phase III neoadjuvant KRISTINE trial. In CANCER RESEARCH. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.
MLA:
Hurvitz, Sara A., et al. "Treatment-related amenorrhea with T-DM1 plus pertuzumab (KP) is lower than with docetaxel/carboplatin/ trastuzumab/pertuzumab (TCHP) in the phase III neoadjuvant KRISTINE trial." Proceedings of the CANCER RESEARCH PHILADELPHIA: AMER ASSOC CANCER RESEARCH, 2021.
BibTeX: Download